Synapse - Works

Results (115370)

Intensive induction chemotherapy vs hypomethylating agents + venetoclax (HMA/VEN) in NPM1-mutant newly diagnosed acute myeloid leukemia (AML) - A multicenter cohort study

Meeting Abstract

Bewersdorf, J. P.; Shimony, S.; Shallis, R. M.; Liu, Y. W.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A. D.; Stein, E. M.; Marcucci, G.; Lindsley, C.; more...
Blood (2023)

Fulltext@MSK | Save

Impact of therapy sequence on survival outcomes among patients with relapsed or refractory mature T and NK cell neoplasms: A global retrospective cohort study

Meeting Abstract

Sorial, M. N.; Koh, M. J.; Boussi, L.; Han, J. X.; Peng, L.; Eche-Ugwu, I. J.; Duan, R.; Lei, M. M.; Miranda, E.; Chiattone, C.; more...
Blood (2023)

Fulltext@MSK | Save

Long-term efficacy and safety of elranatamab monotherapy in the phase 2 magnetismm-3 trial in relapsed or refractory multiple myeloma (RRMM)

Meeting Abstract

Tomasson, M.; Iida, S.; Niesvizky, R.; Mohty, M.; Bahlis, N. J.; Martinez-Lopez, J.; Koehne, G.; Otero, P. R.; Prince, H. M.; Viqueira, A.; more...
Blood (2023)

Fulltext@MSK | Save

Molecular attributes of CAR T cell fitness in patients with chronic lymphocytic leukemia

Meeting Abstract

Mi, X.; Yuan, D.; Murray, R.; Huuhtanen, J.; Zhang, B.; Quentin, J.; Shestova, O.; Porter, D. L.; Mustjoki, S.; Gill, S.; more...
Blood (2023)

Fulltext@MSK | Save

Evaluation of the Molecular International Prognostic Scoring System (IPSS-M) in patients (pts) with myelodysplastic syndromes/neoplasms (MDS) with missing molecular data

Meeting Abstract

Kewan, T.; Bewersdorf, J. P.; Blaha, O.; Stahl, M.; Al Ali, N. H.; DeZern, A. E.; Sekeres, M. A.; Carraway, H. E.; Desai, P.; Griffiths, E. A.; more...
Blood (2023)

Fulltext@MSK | Save

A first-in-human phase 1 trial of NX-2127, a first-in-class Bruton's tyrosine kinase (BTK) dual-targeted protein degrader with immunomodulatory activity, in patients with relapsed/refractory B cell malignancies

Meeting Abstract

Danilov, A.; Tees, M. T.; Patel, K.; Wierda, W. G.; Patel, M.; Flinn, I. W.; Latif, T.; Ai, W. Y.; Thompson, M. C.; Wang, M. L.; more...
Blood (2023)

Fulltext@MSK | Save

Artificial intelligence and venous thromboembolism: Talking to the experts

Meeting Abstract

Gupta, A.; Lam, B. D.; Zerbey, S.; Robertson, W.; Rosovsky, R. P.; Lake, L.; Dodge, L.; Adamski, A.; Reyes, N.; Abe, K.; more...
Blood (2023)

Fulltext@MSK | Save

KB-Lanra 1001: A phase 1b/2 study of safety, PK, PD, and preliminary efficacy of the selective SYK inhibitor lanraplenib in combination with the FLT3 inhibitor gilteritinib in FLT3-mutated R/R AML

Meeting Abstract

Arnan, M.; Patel, A. A.; Esteve, J.; Morris, L.; Schiller, G. J.; Swords, R. T.; Alonso-Dominguez, J. M.; Michaelis, L. C.; Daver, N.; Carvajal, L. A.; more...
Blood (2023)

Fulltext@MSK | Save

Updated results of the phase I BALLI-01 trial of UCART22 Process 2 (P2), an anti-CD22 allogeneic CAR-T cell product manufactured by Cellectis Biologics, in patients with relapsed or refractory (R/R) CD22+ B-cell acute lymphoblastic leukemia (B-ALL)

Meeting Abstract

Jain, N.; Chevallier, P.; Liu, H. T.; Schiller, G. J.; Méar, J. B.; DeAngelo, D. J.; Curran, K. J.; Grupp, S.; Baruchel, A.; Balsat, M.; more...
Blood (2023)

Fulltext@MSK | Save

Post allogeneic stem cell transplant outcomes following response to hypomethylating agent therapy in myelodysplastic syndromes are predicted by persistent international prognostic scoring system-molecular risk

Meeting Abstract

Frumm, S. M.; Kim, H. T.; Kelkar, A. H.; Ho, V. T.; Gooptu, M.; Gibson, C. J.; Koreth, J.; Shapiro, R. M.; Romee, R.; Nikiforow, S.; more...
Blood (2023)

Fulltext@MSK | Save